Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythromycin gel versus breast protector for nipple fissure in breastfeeding women
IRCT20181214041970N1Phase 3Completed
- Sponsor
- Sabzevar University of Medical Sciences
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of erythromycin in cracked nipple (2 arms), sponsored by Sabzevar University of Medical Sciences. Primary endpoints: Breast fissure severity and Pain severity. Started Jan 2020; status: completed.
02
Drugs
erythromycin
03
Conditions
cracked nipple
Beyond the preview
Go deeper on IRCT20181214041970N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181214041970N1.